Dr. Gary Onik
Providing the best possible treatment of your High Risk or Recurrent Cancer.
The Center for High Risk and Recurrent Cancer is the world leader in the immunotherapy of cancer. Immunotherapy is the forefront of cancer management and offers the hope of potential cure to patients who previously had only palliative options.
Welcome to
THE CENTER FOR HIGH RISK & RECURRENT CANCER
Our Mission is to offer the most advanced treatment options to men who have high risk prostate cancer or who have suffered a recurrence of their prostate cancer. If you have been advised that your prostate cancer is classified as High Risk (high PSA, Gleason score 8 or greater, or large volume tumor) or after previous treatment has returned, or if your PSA levels are rising after your primary treatment has been completed, you have come to the right place - we can help.
New Hope for Patients with
End-Stage Metastatic Cancer
There is now new hope for patients with end stage metastatic prostate cancer who have their disease progressing despite hormonal therapy. This situation is called castrate resistant prostate cancer or CRPC. This is usually the last stage of prostate cancer and the point at which chemotherapy is usually started. Chemotherapy can add a few extra months of life for a patient, but long term responses are rare.
Dr. Onik is currently using a new treatment utilizing the patients own immune system to fight the cancer. Results have been dramatic as shown in the following case study.
Before
